{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:44:14Z","timestamp":1795023854775,"version":"4.10.2"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T00:00:00Z","timestamp":1665446400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG10161"],"award-info":[{"award-number":["P30AG10161"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG10161"],"award-info":[{"award-number":["P30AG10161"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG055770"],"award-info":[{"award-number":["R01AG055770"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Chronic neuroinflammation is one of the hallmarks of late-onset Alzheimer\u2019s disease (AD) dementia pathogenesis. Carrying the apolipoprotein \u03b54 (<jats:italic>APOE4<\/jats:italic>) allele has been associated with an accentuated response to brain inflammation and increases the risk of AD dementia progression. Among inflammation signaling pathways, aberrant eicosanoid activation plays a prominent role in neurodegeneration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Using brains from the Religious Order Study (ROS), this study compared measures of brain eicosanoid lipidome in older persons with AD dementia to age-matched controls with no cognitive impairment (NCI), stratified by<jats:italic>APOE<\/jats:italic>genotype.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Lipidomic analysis of the dorsolateral prefrontal cortex demonstrated lower levels of omega-3 fatty acids eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and DHA-derived neuroprotectin D1 (NPD-1) in persons with AD dementia, all of which associated with lower measures of cognitive function. A significant interaction was observed between carrying the<jats:italic>APOE4<\/jats:italic>allele and higher levels of both pro-inflammatory lipids and pro-resolving eicosanoid lipids on measures of cognitive performance and on neuritic plaque burden. Furthermore, analysis of lipid metabolism pathways implicated activation of calcium-dependent phospholipase A2 (cPLA2), 5-lipoxygenase (5-LOX), and soluble epoxide hydrolase (sEH) enzymes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings implicate activation of the eicosanoid lipidome in the chronic unresolved state of inflammation in AD dementia, which is increased in carriers of the<jats:italic>APOE4<\/jats:italic>allele, and identify potential therapeutic targets for resolving this chronic inflammatory state.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13195-022-01084-7","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T02:02:59Z","timestamp":1665453779000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Eicosanoid lipidome activation in post-mortem brain tissues of individuals with APOE4 and Alzheimer\u2019s dementia"],"prefix":"10.1186","volume":"14","author":[{"given":"Brandon","family":"Ebright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaac","family":"Assante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy A.","family":"Poblete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlon V.","family":"Duro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Arvanitakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan G.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hussein N.","family":"Yassine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,11]]},"reference":[{"issue":"5","key":"1084_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1474-4422(18)30499-X","volume":"18","author":"Collaborators, G.B.D.N","year":"2019","unstructured":"Collaborators, G.B.D.N. Global, regional, and national burden of neurological disorders, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(5):459\u201380.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1084_CR2","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","volume":"3","author":"R Brookmeyer","year":"2007","unstructured":"Brookmeyer R, et al. Forecasting the global burden of Alzheimer's disease. Alzheimers Dement. 2007;3(3):186\u201391.","journal-title":"Alzheimers Dement"},{"issue":"1-2","key":"1084_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0165-5728(02)00050-4","volume":"126","author":"N Abbas","year":"2002","unstructured":"Abbas N, et al. Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice. J Neuroimmunol. 2002;126(1-2):50\u20137.","journal-title":"J Neuroimmunol"},{"issue":"6","key":"1084_CR4","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S0197-4580(99)00065-2","volume":"20","author":"WC Benzing","year":"1999","unstructured":"Benzing WC, et al. Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice. Neurobiol Aging. 1999;20(6):581\u20139.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"1084_CR5","doi-asserted-by":"publisher","first-page":"7301","DOI":"10.18632\/oncotarget.14236","volume":"8","author":"J Chen","year":"2017","unstructured":"Chen J, et al. Polyunsaturated fatty acids ameliorate aging via redox-telomere-antioncogene axis. Oncotarget. 2017;8(5):7301\u201314.","journal-title":"Oncotarget"},{"issue":"2","key":"1084_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12035-011-8174-4","volume":"43","author":"DT Stark","year":"2011","unstructured":"Stark DT, Bazan NG. Neuroprotectin D1 induces neuronal survival and downregulation of amyloidogenic processing in Alzheimer's disease cellular models. Mol Neurobiol. 2011;43(2):131\u20138.","journal-title":"Mol Neurobiol"},{"issue":"11","key":"1084_CR7","doi-asserted-by":"crossref","first-page":"e1256","DOI":"10.1212\/WNL.0000000000007094","volume":"92","author":"KA Walker","year":"2019","unstructured":"Walker KA, et al. Systemic inflammation during midlife and cognitive change over 20 years: The ARIC Study. Neurology. 2019;92(11):e1256\u201367.","journal-title":"Neurology"},{"issue":"3","key":"1084_CR8","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.3233\/JAD-180469","volume":"66","author":"KA Walker","year":"2018","unstructured":"Walker KA, et al. The Association of Mid- and Late-Life Systemic Inflammation with Brain Amyloid Deposition: The ARIC-PET Study. J Alzheimers Dis. 2018;66(3):1041\u201352.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1084_CR9","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3233\/JAD-2005-7104","volume":"7","author":"S Chen","year":"2005","unstructured":"Chen S, et al. Isoform-specific effects of apolipoprotein E on secretion of inflammatory mediators in adult rat microglia. J Alzheimers Dis. 2005;7(1):25\u201335.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"1084_CR10","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1385\/JMN:23:3:205","volume":"23","author":"L Guo","year":"2004","unstructured":"Guo L, LaDu MJ, Van Eldik LJ. A dual role for apolipoprotein e in neuroinflammation: anti- and pro-inflammatory activity. J Mol Neurosci. 2004;23(3):205\u201312.","journal-title":"J Mol Neurosci"},{"issue":"3","key":"1084_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.nbd.2005.05.002","volume":"20","author":"G Ophir","year":"2005","unstructured":"Ophir G, et al. Apolipoprotein E4 enhances brain inflammation by modulation of the NF-kappaB signaling cascade. Neurobiol Dis. 2005;20(3):709\u201318.","journal-title":"Neurobiol Dis"},{"issue":"9","key":"1084_CR12","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.neurobiolaging.2007.11.014","volume":"30","author":"MP Vitek","year":"2009","unstructured":"Vitek MP, Brown CM, Colton CA. APOE genotype-specific differences in the innate immune response. Neurobiol Aging. 2009;30(9):1350\u201360.","journal-title":"Neurobiol Aging"},{"issue":"4","key":"1084_CR13","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/glia.22289","volume":"60","author":"Y Zhu","year":"2012","unstructured":"Zhu Y, et al. APOE genotype alters glial activation and loss of synaptic markers in mice. Glia. 2012;60(4):559\u201369.","journal-title":"Glia"},{"issue":"1","key":"1084_CR14","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13024-022-00549-5","volume":"17","author":"S Wang","year":"2022","unstructured":"Wang S, et al. Calcium-dependent cytosolic phospholipase A2 activation is implicated in neuroinflammation and oxidative stress associated with ApoE4. Mol Neurodegener. 2022;17(1):42.","journal-title":"Mol Neurodegener"},{"issue":"10","key":"1084_CR15","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1172\/JCI25420","volume":"115","author":"WJ Lukiw","year":"2005","unstructured":"Lukiw WJ, et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest. 2005;115(10):2774\u201383.","journal-title":"J Clin Invest"},{"issue":"1","key":"1084_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jalz.2013.12.024","volume":"11","author":"X Wang","year":"2015","unstructured":"Wang X, et al. Resolution of inflammation is altered in Alzheimer's disease. Alzheimers Dement. 2015;11(1):40\u201350 e1-2.","journal-title":"Alzheimers Dement"},{"issue":"10","key":"1084_CR17","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/gerona\/62.10.1120","volume":"62","author":"A Cherubini","year":"2007","unstructured":"Cherubini A, et al. Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2007;62(10):1120\u20136.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"1084_CR18","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3109\/09637480903348098","volume":"61","author":"S Gonz\u00e1lez","year":"2010","unstructured":"Gonz\u00e1lez S, et al. The relationship between dietary lipids and cognitive performance in an elderly population. Int J Food Sci Nutr. 2010;61(2):217\u201325.","journal-title":"Int J Food Sci Nutr"},{"issue":"4","key":"1084_CR19","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/ajcn\/77.4.803","volume":"77","author":"B Heude","year":"2003","unstructured":"Heude B, et al. Cognitive decline and fatty acid composition of erythrocyte membranes--The EVA Study. Am J Clin Nutr. 2003;77(4):803\u20138.","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"1084_CR20","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/ajcn\/88.3.714","volume":"88","author":"C Samieri","year":"2008","unstructured":"Samieri C, et al. Low plasma eicosapentaenoic acid and depressive symptomatology are independent predictors of dementia risk. Am J Clin Nutr. 2008;88(3):714\u201321.","journal-title":"Am J Clin Nutr"},{"key":"1084_CR21","doi-asserted-by":"publisher","first-page":"102883","DOI":"10.1016\/j.ebiom.2020.102883","volume":"59","author":"IC Arellanes","year":"2020","unstructured":"Arellanes IC, et al. Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial. EBioMedicine. 2020;59:102883.","journal-title":"EBioMedicine"},{"key":"1084_CR22","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.plefa.2015.04.005","volume":"99","author":"D Bibus","year":"2015","unstructured":"Bibus D, Lands B. Balancing proportions of competing omega-3 and omega-6 highly unsaturated fatty acids (HUFA) in tissue lipids. Prostaglandins Leukot Essent Fatty Acids. 2015;99:19\u201323.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"5","key":"1084_CR23","first-page":"376","volume":"7","author":"X Chen","year":"2012","unstructured":"Chen X, Guo C, Kong J. Oxidative stress in neurodegenerative diseases. Neural Regen Res. 2012;7(5):376\u201385.","journal-title":"Neural Regen Res"},{"issue":"10","key":"1084_CR24","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1113\/jphysiol.2012.230078","volume":"590","author":"R Agrawal","year":"2012","unstructured":"Agrawal R, Gomez-Pinilla F. \u2018Metabolic syndrome\u2019 in the brain: deficiency in omega-3 fatty acid exacerbates dysfunctions in insulin receptor signalling and cognition. J Physiol. 2012;590(10):2485\u201399.","journal-title":"J Physiol"},{"issue":"3","key":"1084_CR25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1002\/alz.12195","volume":"17","author":"A Thomas","year":"2020","unstructured":"Thomas A, et al. Blood polyunsaturated omega-3 fatty acids, brain atrophy, cognitive decline, and dementia risk. Alzheimers Dement. 2020;17(3):407\u201316.","journal-title":"Alzheimers Dement."},{"issue":"1","key":"1084_CR26","doi-asserted-by":"publisher","first-page":"e15816","DOI":"10.1371\/journal.pone.0015816","volume":"6","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, et al. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARgamma-mediated mechanisms in Alzheimer's disease models. PLoS One. 2011;6(1):e15816.","journal-title":"PLoS One"},{"issue":"573","key":"1084_CR27","doi-asserted-by":"publisher","first-page":"eabb1206","DOI":"10.1126\/scitranslmed.abb1206","volume":"12","author":"A Ghosh","year":"2020","unstructured":"Ghosh A, et al. An epoxide hydrolase inhibitor reduces neuroinflammation in a mouse model of Alzheimer's disease. Sci Transl Med. 2020;12(573):eabb1206.","journal-title":"Sci Transl Med"},{"issue":"4","key":"1084_CR28","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1007\/s12035-015-9544-0","volume":"53","author":"M Zhu","year":"2016","unstructured":"Zhu M, et al. Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Abeta42 Phagocytosis. Mol Neurobiol. 2016;53(4):2733\u201349.","journal-title":"Mol Neurobiol"},{"issue":"3","key":"1084_CR29","doi-asserted-by":"publisher","first-page":"975","DOI":"10.3233\/JAD-191017","volume":"74","author":"N Tomaszewski","year":"2020","unstructured":"Tomaszewski N, et al. Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial. J Alzheimers Dis. 2020;74(3):975\u201390.","journal-title":"J Alzheimers Dis"},{"key":"1084_CR30","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13195-016-0194-x","volume":"8","author":"HN Yassine","year":"2016","unstructured":"Yassine HN, Rawat V, Mack WJ, Quinn JF, Yurko-Mauro K, Bailey-Hall E, et al. The effect of APOE genotype on the delivery of DHA to cerebrospinal fluid in Alzheimer's disease. Alzheimers Res Ther. 2016;8:25.","journal-title":"Alzheimers Res Ther"},{"key":"1084_CR31","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.neurobiolaging.2015.09.011","volume":"37","author":"JM Farfel","year":"2016","unstructured":"Farfel JM, et al. Association of APOE with tau-tangle pathology with and without \u03b2-amyloid. Neurobiol Aging. 2016;37:19\u201325.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"1084_CR32","doi-asserted-by":"publisher","first-page":"NS20180203","DOI":"10.1042\/NS20180203","volume":"3","author":"HC Hunsberger","year":"2019","unstructured":"Hunsberger HC, et al. The role of APOE4 in Alzheimer's disease: strategies for future therapeutic interventions. Neuronal Signal. 2019;3(2):NS20180203.","journal-title":"Neuronal Signal"},{"key":"1084_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.neuroscience.2015.06.005","volume":"301","author":"L Jiang","year":"2015","unstructured":"Jiang L, et al. Effects of ApoE on intracellular calcium levels and apoptosis of neurons after mechanical injury. Neuroscience. 2015;301:375\u201383.","journal-title":"Neuroscience"},{"issue":"5","key":"1084_CR34","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.bbadis.2015.12.016","volume":"1862","author":"AR Nelson","year":"2016","unstructured":"Nelson AR, et al. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. Biochim Biophys Acta. 2016;1862(5):887\u2013900.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"1084_CR35","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.bbadis.2006.10.014","volume":"1772","author":"X Zhu","year":"2007","unstructured":"Zhu X, et al. Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta. 2007;1772(4):494\u2013502.","journal-title":"Biochim Biophys Acta"},{"key":"1084_CR36","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neurobiolaging.2022.06.011","volume":"118","author":"M Seto","year":"2022","unstructured":"Seto M, et al. RNASE6 is a novel modifier of APOE-epsilon4 effects on cognition. Neurobiol Aging. 2022;118:66\u201376.","journal-title":"Neurobiol Aging"},{"issue":"505","key":"1084_CR37","doi-asserted-by":"publisher","first-page":"eaau2291","DOI":"10.1126\/scitranslmed.aau2291","volume":"11","author":"Y Deming","year":"2019","unstructured":"Deming Y, et al. The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk. Sci Transl Med. 2019;11(505):eaau2291.","journal-title":"Sci Transl Med"},{"issue":"4","key":"1084_CR38","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.bcp.2013.11.021","volume":"88","author":"SE Hickman","year":"2014","unstructured":"Hickman SE, El Khoury J. TREM2 and the neuroimmunology of Alzheimer's disease. Biochem Pharmacol. 2014;88(4):495\u20138.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"1084_CR39","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/jamaneurol.2017.4365","volume":"75","author":"A Solomon","year":"2018","unstructured":"Solomon A, et al. Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial. JAMA Neurol. 2018;75(4):462\u201370.","journal-title":"JAMA Neurol"},{"issue":"3 Pt 1","key":"1084_CR40","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1212\/WNL.45.3.555","volume":"45","author":"R Mayeux","year":"1995","unstructured":"Mayeux R, et al. Synergistic effects of traumatic head injury and apolipoprotein-epsilon 4 in patients with Alzheimer's disease. Neurology. 1995;45(3 Pt 1):555\u20137.","journal-title":"Neurology"},{"issue":"1","key":"1084_CR41","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/s41398-017-0064-8","volume":"8","author":"MJ Rawle","year":"2018","unstructured":"Rawle MJ, et al. Apolipoprotein-E (Apoe) epsilon4 and cognitive decline over the adult life course. Transl Psychiatry. 2018;8(1):18.","journal-title":"Transl Psychiatry"},{"issue":"12","key":"1084_CR42","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s12170-014-0418-1","volume":"8","author":"HJ Murff","year":"2014","unstructured":"Murff HJ, Edwards TL. Endogenous Production of Long-Chain Polyunsaturated Fatty Acids and Metabolic Disease Risk. Curr Cardiovasc Risk Rep. 2014;8(12):418.","journal-title":"Curr Cardiovasc Risk Rep"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01084-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-01084-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-01084-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T14:48:03Z","timestamp":1728139683000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-01084-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,11]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1084"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-01084-7","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,11]]},"assertion":[{"value":"26 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of Rush University Medical Center and the University of Southern California and all participants provided informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"152"}}